<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30229826</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>23</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">2284-0729</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>22</Volume>                    <Issue>17</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>European review for medical and pharmacological sciences</Title>                <ISOAbbreviation>Eur Rev Med Pharmacol Sci</ISOAbbreviation>            </Journal>            <ArticleTitle>Correlations between the expression of C-erB-2, CD34 and ER in breast cancer patients and the signs of conventional ultrasonography and ultrasound elastography.</ArticleTitle>            <Pagination>                <MedlinePgn>5539-5545</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">15815</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.26355/eurrev_201809_15815</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to investigate the correlations between the expression of human epidermal growth factor receptor 2 (C-erB-2), CD34, and estrogen receptor (ER) in breast cancer (BC) patients, and the signs of conventional ultrasonography and ultrasound elastography.</AbstractText>                <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Clinical data of 88 patients who were pathologically diagnosed as breast cancer were retrospectively analyzed. HI VISION Avius color ultrasound device was used to perform ultrasound and related ultrasound parameters were analyzed. Expressions of C-erB-2, CD34, and ER were detected by immunohistochemistry.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a correlation between positive expression of C-erB-2 and the blood supply, lymph node metastasis and microcalcification in patients (p &lt; 0.05). Patients were divided into high expression group and low expression group according to the median expression level of CD34. Expression of CD34 was correlated with the ultrasound sign of lymph node metastasis (p &lt; 0.05). Positive expression of ER was correlated with the morphology, margin, and perimeter of the tumor (p &lt; 0.05). Expression levels of C-erB-2, CD34, and ER were found to be increased in BC patients.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Combination of upregulated expression of C-erB-2, CD34, and ER and signs of ultrasound can improve the diagnosis of BC.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Y</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Ultrasound Diagnosis, China Meitan General Hospital, Chaoyang District, Beijing, P.R. China. jzhang76@sina.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xiong</LastName>                    <ForeName>W</ForeName>                    <Initials>W</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Xu</LastName>                    <ForeName>J-M</ForeName>                    <Initials>JM</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Y-X</ForeName>                    <Initials>YX</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>J</ForeName>                    <Initials>J</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Italy</Country>            <MedlineTA>Eur Rev Med Pharmacol Sci</MedlineTA>            <NlmUniqueID>9717360</NlmUniqueID>            <ISSNLinking>1128-3602</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30229826</ArticleId>            <ArticleId IdType="doi">10.26355/eurrev_201809_15815</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>